Immune checkpoint inhibitors are drugs designed to block proteins that prevent T cells from attacking cancer cells. By inhibiting these checkpoints, such as PD-1/PD-L1 and CTLA-4, these therapies enhance the immune response against cancer. Immune checkpoint inhibitors have been effective in treating various cancers, including melanoma and lung cancer.
